Revvity, Inc. (NYSE:RVTY) Q1 2024 Earnings Call Transcript :

Revvity, Inc. beats earnings expectations. Reported EPS is $0.98, expectations were $0.94. Revvity, Inc.

Related Keywords

China , San Diego , California , United States , Chinese , America , Joshua Waldman , Michael Ryskin , Vijay Kumar , Max Krakowiak , Josh Waldman , Oxford Immunotec , Steve Willoughby , Andrew Cooper , Raymond James , Doug Schenkel , Patrick Donnelly , Jack Meehan , Prahlad Singh , Matt Sykes , Matthew Sykes , Nephron Research , Cleveland Research , Life Sciences Reagents , Life Sciences , Our Life Sciences Instrument , Revvity Omics Lab , Life Sciences Or Applied Genomics , Revvity Signals Software , Reagents Technology Licensing , Wolfe Research , Our Signal Software , Fox Foundation , Republican Congress Members , Tour Life Sciences , Goldman Sachs , Specialty Pharma Services , Revvity Inc , Call Transcript April , Earnings Conference , Chief Executive Officer , Senior Vice President , Chief Financial , Safe Harbor , Newborn Screening , Applied Genomics , Gene Lay , Revvity Omics , Signals Clinical , Signals Synergy , Investor Day , Investor Relations , Life Sciences Instrument , Signal Software , Buying These , Latest Insider , Life Science , Software Signals , Signals Clinicals ,